Delisting risk
SBC Medical Group Warrants (SBCWW)
Public warrants to acquire shares in a Japan-centered clinic-management organization.
$0.3150
At close+0.02 (+5.00%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 47 | 62 | 55 | 53 | 53 | 44 | 47 | 43 | 43 | 40 | 43 | 49 |
| Cost of revenue | 14 | 19 | 15 | 14 | 10 | 11 | 10 | 13 | 13 | 11 | 13 | 13 |
| Gross profit | 33 | 43 | 40 | 39 | 43 | 34 | 38 | 30 | 31 | 29 | 30 | 36 |
| 13 | 19 | 15 | 12 | 29 | 29 | 14 | 15 | 15 | 16 | 13 | 17 | |
| 13 | 19 | 14 | 12 | 29 | 14 | 13 | 14 | 14 | 19 | 12 | 0 | |
| Selling & marketing | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | −2 | 1 | 0 |
| General & administrative | 13 | 19 | 13 | 11 | 28 | 14 | 12 | 13 | 14 | 21 | 12 | 0 |
| Other expenses | 0 | 0 | 1 | 0 | 1 | 15 | 1 | 1 | 1 | −3 | 0 | 17 |
| Operating income | 20 | 24 | 24 | 27 | 14 | 5 | 24 | 15 | 16 | 13 | 18 | 19 |
| 1 | 0 | 3 | 0 | −1 | 1 | 7 | −1 | 3 | 6 | 1 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | −1 | 0 | −3 | 0 | 1 | −1 | −7 | 1 | −3 | −6 | −1 | 0 |
| Income before tax | 21 | 24 | 27 | 27 | 13 | 6 | 31 | 14 | 19 | 19 | 19 | 19 |
| Income tax expense | 13 | 9 | 8 | 9 | 10 | 0 | 10 | 11 | 6 | 4 | 8 | 8 |
| Net income from continuing operations | 8 | 14 | 19 | 19 | 3 | 7 | 21 | 2 | 13 | 14 | 11 | 11 |
| Net income | 8 | 14 | 19 | 18 | 3 | 7 | 22 | 2 | 13 | 14 | 11 | 11 |
| EPS, basic | −$0.02 | $1.71 | $3.52 | $0.44 | $0.00 | $0.06 | $0.21 | $0.02 | $0.12 | $0.14 | $0.11 | $0.10 |
| EPS, diluted | −$0.02 | $1.71 | $3.52 | $0.20 | $0.00 | $0.06 | $0.21 | $0.02 | $0.12 | $0.14 | $0.11 | $0.10 |
| Weighted average shares, basic | 5 | 8 | 5 | 5 | 0 | 103 | 103 | 104 | 103 | 103 | 103 | 103 |
| Weighted average shares, diluted | 5 | 8 | 5 | 5 | 0 | 103 | 103 | 104 | 103 | 103 | 103 | 103 |
| EBITDA | 24 | 26 | 28 | 28 | 14 | 7 | 32 | 14 | 19 | 19 | 20 | 19 |
| Depreciation & amortization | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| EBIT | 21 | 24 | 27 | 27 | 13 | 6 | 31 | 14 | 19 | 19 | 19 | 19 |